Search Results

There are 11311 results for: content related to: Subacute cutaneous lupus erythematosus after treatment with capecitabine

  1. You have free access to this content
    Incidence and relative risk of grade 3 and 4 diarrhoea in patients treated with capecitabine or 5-fluorouracil: a meta-analysis of published trials

    British Journal of Clinical Pharmacology

    Volume 78, Issue 6, December 2014, Pages: 1228–1237, Roberto Iacovelli, Filippo Pietrantonio, Antonella Palazzo, Claudia Maggi, Francesca Ricchini, Filippo de Braud and Maria Di Bartolomeo

    Version of Record online : 20 NOV 2014, DOI: 10.1111/bcp.12449

  2. Development of an Extended-Release Formulation of Capecitabine Making Use of In Vitro–In Vivo Correlation Modelling

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 2, February 2014, Pages: 478–484, Jelte Meulenaar, Ron J. Keizer, Jos H. Beijnen, Jan H. M. Schellens, Alwin D. R. Huitema and Bastiaan Nuijen

    Version of Record online : 5 DEC 2013, DOI: 10.1002/jps.23779

  3. Hand-Foot Syndrome in Patients Treated With Capecitabine-Containing Combination Chemotherapy

    The Journal of Clinical Pharmacology

    Volume 44, Issue 10, October 2004, Pages: 1166–1172, Young Seol Heo, Heung Moon Chang, Tae Won Kim, Min-Hee Ryu, Jin-Hee Ahn, Sung Bae Kim, Jung Shin Lee, Woo Kun Kim, Hye Kyung Cho and Yoon-Koo Kang

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270004268321

  4. Emerging Role of Capecitabine in Gastric Cancer

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 29, Issue 3, March 2009, Pages: 318–330, Dr. Pasquale Camella, Dr. Luca Franco, Dr. Rossana Casaretti, Dr. Simona de Portu and Dr. Enrica Menditto

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.29.3.318

  5. Safety and Pharmacokinetics of Sorafenib Combined With Capecitabine in Patients With Advanced Solid Tumors: Results of a Phase 1 Trial

    The Journal of Clinical Pharmacology

    Volume 51, Issue 12, December 2011, Pages: 1674–1684, Dr Ahmad Awada, Dr Thierry Gil, Dr Nicolas Whenham, Dr Julie Van Hamme, Dr Tatiana Besse-Hammer, Dr Erich Brendel, Dr Heinz Delesen, Dr Miranda C. Joosten, Dr Chetan D. Lathia, Dr Bienvenu A. Loembé, Dr Martine Piccart-Ghebart and Dr Alain Hendlisz

    Version of Record online : 12 MAR 2013, DOI: 10.1177/0091270010386226

  6. Exploring the intracellular pharmacokinetics of the 5-fluorouracil nucleotides during capecitabine treatment

    British Journal of Clinical Pharmacology

    Volume 81, Issue 5, May 2016, Pages: 949–957, Ellen J. B. Derissen, Bart A. W. Jacobs, Alwin D. R. Huitema, Hilde Rosing, Jan H. M. Schellens and Jos H. Beijnen

    Version of Record online : 2 MAR 2016, DOI: 10.1111/bcp.12877

  7. You have free access to this content
    Capecitabine for the treatment for advanced gastric cancer: efficacy, safety and ethnicity

    Journal of Clinical Pharmacy and Therapeutics

    Volume 37, Issue 3, June 2012, Pages: 266–275, Y. Ma, L. Tang, H.-X. Wang, Y.-C. Xu, Y. Ma and F.-C. Zhang

    Version of Record online : 25 SEP 2011, DOI: 10.1111/j.1365-2710.2011.01289.x

  8. You have free access to this content
    Costs associated with complications are lower with capecitabine than with 5-fluorouracil in patients with colorectal cancer

    Cancer

    Volume 115, Issue 7, 1 April 2009, Pages: 1412–1423, Edward Chu, Kathy L. Schulman, Susan Zelt and Xue Song

    Version of Record online : 4 FEB 2009, DOI: 10.1002/cncr.24131

  9. An APCI LC-MS/MS method for routine determination of capecitabine and its metabolites in human plasma

    Journal of Mass Spectrometry

    Volume 45, Issue 6, June 2010, Pages: 670–677, Damien Montange, Michel Bérard, Martin Demarchi, Patrice Muret, Sarah Piédoux, Jean Pierre Kantelip and Bernard Royer

    Version of Record online : 13 MAY 2010, DOI: 10.1002/jms.1759

  10. Comparison of the 5-Fluorouracil-Warfarin and Capecitabine-Warfarin Drug Interactions

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 30, Issue 12, December 2010, Pages: 1259–1265, Dr. Sachin R. Shah, Dr. Randall Martin, Dr. Jonathan E. Dowell and Dr. Sarah M. Gressett Ussery

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.30.12.1259

  11. Capecitabine combined with docetaxel versus vinorelbine followed by capecitabine maintenance medication for first-line treatment of patients with advanced breast cancer: Phase 3 randomized trial

    Cancer

    Volume 121, Issue 19, October 1, 2015, Pages: 3412–3421, Jiayu Wang, Binghe Xu, Peng Yuan, Fei Ma, Qing Li, Pin Zhang, Ruigang Cai, Ying Fan, Yang Luo and Qiao Li

    Version of Record online : 19 JUN 2015, DOI: 10.1002/cncr.29492

  12. Investigation of 5-FU disposition after oral administration of capecitabine, a triple-prodrug of 5-FU, using a physiologically based pharmacokinetic model in a human cancer xenograft model: comparison of the simulated 5-FU exposures in the tumour tissue between human and xenograft model

    Biopharmaceutics & Drug Disposition

    Volume 22, Issue 1, January 2001, Pages: 1–14, Yuko Tsukamoto, Yukio Kato, Masako Ura, Ikuo Horii, Tohru Ishikawa, Hideo Ishitsuka and Yuichi Sugiyama

    Version of Record online : 5 NOV 2001, DOI: 10.1002/bdd.250

  13. You have free access to this content
    Augmentation of the antitumor activity of capecitabine by a tumor selective dihydropyrimidine dehydrogenase inhibitor, RO0094889

    International Journal of Cancer

    Volume 106, Issue 5, 20 September 2003, Pages: 799–805, Mika Endo, Masanori Miwa, Hiroyuki Eda, Masako Ura, Hiromi Tanimura, Tohru Ishikawa, Taeko Miyazaki-Nose, Kazuo Hattori, Nobuo Shimma, Hisafumi Yamada-Okabe and Hideo Ishitsuka

    Version of Record online : 9 JUN 2003, DOI: 10.1002/ijc.11276

  14. A Dynamic Model of Hand-and-Foot Syndrome in Patients Receiving Capecitabine

    Clinical Pharmacology & Therapeutics

    Volume 85, Issue 4, April 2009, Pages: 418–425, E Hénin, B You, E VanCutsem, PM Hoff, J Cassidy, C Twelves, KP Zuideveld, F Sirzen, C Dartois, G Freyer, M Tod and P Girard

    Version of Record online : 10 DEC 2008, DOI: 10.1038/clpt.2008.220

  15. Crystal Structure and Tautomerism of Capecitabine

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 2, February 2014, Pages: 587–593, Maura Malińska, Piotr Krzeczyński, Ewelina Czerniec-Michalik, Kinga Trzcińska, Piotr Cmoch, Andrzej Kutner and Krzysztof Woźniak

    Version of Record online : 30 DEC 2013, DOI: 10.1002/jps.23831

  16. You have free access to this content
    Identification of novel germline polymorphisms governing capecitabine sensitivity

    Cancer

    Volume 118, Issue 16, 15 August 2012, Pages: 4063–4073, Peter H. O'Donnell, Amy L. Stark, Eric R. Gamazon, Heather E. Wheeler, Bridget E. McIlwee, Lidija Gorsic, Hae Kyung Im, R. Stephanie Huang, Nancy J. Cox and M. Eileen Dolan

    Version of Record online : 3 JAN 2012, DOI: 10.1002/cncr.26737

  17. You have free access to this content
    Review of capecitabine as oral treatment of gastric, gastroesophageal, and esophageal cancers

    Cancer

    Volume 107, Issue 2, 15 July 2006, Pages: 221–231, Jaffer Ajani

    Version of Record online : 12 JUN 2006, DOI: 10.1002/cncr.21986

  18. Capecitabine-induced subacute cutaneous lupus erythematosus: Report of a case with positive rechallenge test

    The Journal of Dermatology

    Volume 40, Issue 11, November 2013, Pages: 939–940, Jen-Hsuan Ko, Cheng-I Hsieh, Che-Yi Chou and Kuo-Hsien Wang

    Version of Record online : 23 SEP 2013, DOI: 10.1111/1346-8138.12281

  19. PK/PD Model of Indisulam and Capecitabine: Interaction Causes Excessive Myelosuppression

    Clinical Pharmacology & Therapeutics

    Volume 83, Issue 6, June 2008, Pages: 829–839, AS Zandvliet, WS Siegel-Lakhai, JH Beijnen, W Copalu, M-C Etienne-Grimaldi, G Milano, JHM Schellens and ADR Huitema

    Version of Record online : 12 SEP 2007, DOI: 10.1038/sj.clpt.6100344

  20. Capecitabine and weekly paclitaxel as first-line therapy in Thai patients with metastatic breast cancer

    Asia-Pacific Journal of Clinical Oncology

    Volume 8, Issue 1, March 2012, Pages: 76–82, Imjai CHITAPANARUX, Pimkhuan KAMNERDSUPAPHON, Ekasit THARAVICHITKUL, Vicharn LORVIDHAYA, Hongsin TRAKULTIVAKORN, Songpol SRISUKHO, Areewan SOMWANGPRASERT, Kirati WATCHARACHAN and Vimol SUKTHOMYA

    Version of Record online : 12 JAN 2012, DOI: 10.1111/j.1743-7563.2011.01467.x